46例脑动静脉畸形的MRI和MRA分析

目的：探讨MRI和MRA检查在脑AVM临床诊断中的价值。方法：46例脑动静脉畸形作了常规MRI和MR血管造影,MRI采用SET1、T2加权成像,MRA采用三维时飞跃法。结果：MRI准确显示了46例AVM的瘤巢,11例可见亚急性出血灶,5例可见含铁血黄素沉积,23例病灶区组织软化或萎缩,4例有占位效应。3D-TOF RMA显示41例AVM供血动脉、23例引流静脉。5例加做增强3D-TOF及6例加做2D-TOF后,引流静脉显示明显改善。结论：MRI和MRA结合应用能对脑血管畸形作出较准确的诊断,为临床治疗提供所需的基本信息并对治疗效果作出客观的评价。     

CE-MRA在腹部静脉病变中的应用及诊断价值

目的探讨腹部静脉病变的CE-MRA的表现及临床应用价值。方法回顾性分析47例腹部静脉病变的常规MRI和腹部静脉CE-MRA表现。结果门脉高压28例(肝硬化性22例,非肝硬化性6例),其中1例合并静脉瘤;静脉内瘤栓8例;肿瘤性静脉包绕4例;布-加氏综合征(Budd-chiarrisyndrome,BCS)2例,门静脉海绵状变性(非肿瘤性)2例,肝移植术后3例。CE-MRA清楚显示了门静脉、脾静脉、胃冠状静脉的增粗,食道胃底静脉的曲张;瘤栓所致的腔内低信号区;静脉被肿物推移受压的情况;门静脉、肝静脉、下腔静脉的狭窄、闭塞和侧枝循环的分布范围和程度。常规MRI显示了腹部脏器的原发病变。结论CE-MRA结合常规MRI检查对腹部静脉病变有一定的诊断价值,对临床治疗方案的选择有明确的指导意义。     

MRA在腹部静脉的应用

目的：评价常规ＭＲＡ和动态增强ＭＲＡ在腹部静脉检查中的价值。材料与方法：腹部静脉ＭＲＡ共５７例行５９人次检查。包括２Ｄ ＴＯＦ５１次，２Ｄ ＰＣ１９次，动态增强ＭＲＡ３０次（其中２Ｄ动态增强１０次，３Ｄ动态增强２０次）。５７例中门脉高压者１８例，布加氏综合征８例，门腔静脉分流术前或术后检查６例，原发性和转移性肝癌９例，其他病变６例，正常组１０例。结果：本组ＭＲＡ表现分别为门脉增粗和静脉曲张；下腔静     

Multiphasische, kontrastverstärkte 3D-MR-Angiographie bei fokalen Leberläsionen Erste klinische Erfahrungen

PURPOSE: To investigate the value of multiphase breath-hold 3D gadolinium (Gd)-enhanced MR angiography (MRA) for lesion detection and characterization of focal liver lesions. MATERIALS AND METHODS: Breath-hold 3D Gd-enhanced MRA was performed in 25 patients with benign and malignant hepatic lesions on a 1.5-T MR system using an ultrafast 3D spoiled gradient echo sequence (TR/TE =5/2 ms, FOV=300-450 mm, matrix=256x168, voxel volume=1.8x2.3 x2.5 mm, 64 partitions, central k-space reordering; acquisition time=27 s). Three measurements were done in the arterial, portal venous, and late venous phase. RESULTS: The analysis of the spatial and temporal evolution of contrast enhancement of the 3D-MRA improved significantly (P<0.01) lesion detection and characterization if compared with T1 precontrast, T2-weighted, and T1 postcontrast images. CONCLUSION: Multiphase breath-hold 3D Gd-enhanced MRA imaging is a robust new technique to significantly improve morphological detection of benign and malignant lesions during the early arterial phase and further improves functional characterization of liver lesions by a combination of an arterial, a portal venous, and a late venous phase.Schlüssselw?rter Multiphasisch. MR-Angiographie. Leberl?sionen     

Non-contrast enhanced MR venography using 3D fresh blood imaging (FBI): initial experience.

OBJECTIVE: This study examined the efficacy of 3D-fresh blood imaging (FBI) in patients with venous disease in the iliac region to lower extremity. MATERIALS AND METHODS: Fourteen patients with venous disease were examined [8 deep venous thrombosis (DVT) and 6 varix] by 3D-FBI and 2D-TOF MRA. All FBI images and 2D-TOF images were evaluated in terms of visualization of the disease and compared with conventional X-ray venography (CV). RESULTS: The total scan time of 3D-FBI ranged from 3 min 24 sec to 4 min 52 sec. 3D-FBI was positive in all 23 anatomical levels in which DVT was diagnosed by CV (100% sensitivity) as well as 2D-TOF. The delineation of collateral veins was superior or equal to that of 2D-TOF. 3D-FBI allowed depiction of varices in five of six cases; however, in one case, the evaluation was limited because the separation of arteries from veins was difficult. CONCLUSION: The 3D-FBI technique, which allows iliac to peripheral MR venography without contrast medium within a short acquisition time, is considered clinically useful.     

MR imaging of portal venous thrombosis: correlation with CT and sonography

Fourteen patients with portal venous thrombosis (PVT) diagnosed by CT and/or sonography were studied with MR. Three of the 14 had portal hypertension. The MR findings were compared with those of eight patients with portal hypertension, but without CT or sonographic evidence of PVT. MR imaging showed portal venous thrombosis in all 14 PVT cases. Intraluminal thrombi of less than 5 weeks duration appeared markedly hyperintense relative to liver and muscle on both T1- and T2-weighted images. Older thrombi appeared hyperintense relative to liver and muscle in eight of 11 cases, but only on T2-weighted images. MR showed thrombi in 11% more portal vessels than did CT (MR = 30, CT = 27) and in 28% more vessels than did sonography (MR = 32, sonography = 25). MR also showed 24% more collateral vessels than did CT (MR = 31, CT = 25) and 50% more vessels than did sonography (MR = 33, sonography = 22). Third-echo images (echo time = 96 msec, repetition time = 1500-2150 msec) verified the presence of venous thrombi in 28 (93%) of 30 PVT vessels, and they differentiated flow-related intravascular signal from true thrombi in six (17%) of 36 portal hypertension vessels. We conclude that MR is a valuable tool for imaging portal vein thrombosis. MR is a good substitute for CT and can be more informative than sonography.     

Living related liver transplantation: preoperative magnetic resonance imaging for assessment of hepatic vasculature of donor candidates

Purpose: To evaluate the accuracy of magnetic resonance angiography (MRA) for preoperative assessment of hepatic vascular anatomy in liver donors before living related liver transplantation.

Material and Methods: A total of 55 consecutive living liver donors (mean age 42 years, range 18-68 years) underwent multiphase contrast-enhanced MRA of the hepatic vessels. Two readers categorized vessel visualization on a five-point scale and recorded vascular anatomy or variations thereof for the arterial, portal venous and venous systems. All 55 living liver donors subsequently underwent right hemihepatectomy for hemiliver donation, and preoperative MRA results were correlated with surgical findings.

Results: Overall vessel visualization assessment demonstrated good or very good ratings for the majority of patients. For hepatic arteries, the mean score was 4.4±0.8 (mean±standard deviation), and for the portal venous and venous systems it was 4.6±0.7 and 4.3±0.8, respectively. Among all 55 donors, 16 (29%) demonstrated accessory or replaced hepatic arteries, and seven (13%) and 20 (36%) donors had surgically relevant portal vein (trifurcation or early right posterolateral branching types) and hepatic vein variations, respectively. Correlation coefficients between MRA and surgery were 0.94, 1.00 and 0.91 for hepatic arteries, portal veins and hepatic veins, respectively.

Conclusion: In the preoperative evaluation before living related liver donation, contrast-enhanced MR angiography was a highly accurate, noninvasive tool for visualizing the hepatic vasculature and variations thereof in liver donor candidates.     

Contrast-enhanced MR angiography of abdominal vessels: Is there still a role for angiography?

The purpose of this review article is to describe recent advantages in contrast-enhanced (CE) three-dimensional (3D) magnetic resonance angiography (MRA) in comparison with other vascular imaging techniques, and to discuss their current clinical applications for the imaging of abdominal vessels. Principles and technical considerations are presented and clinical applications are reviewed for different vascular diseases. In ruptured aortic aneurysms and acute dissections CT is the method of first choice. Contrast-enhanced 3D MRA can be well used for therapeutic planning and follow-up in patients with stable disease. A comprehensive MR examination including CE 3D MRA, MR urography and MR nephrogram has the potential to replace the conventional studies for the evaluation of renal vascular disease. It is an accurate method for imaging the origins of coeliac and superior mesenteric arteries, although the image resolution is too low for reliable assessment of the inferior mesenteric artery. Contrast-enhanced 3D MRA has emerged as the method of choice for studying the portal venous system in liver transplant recipients, in patients with portal hypertension and in cases with abdominal tumours for preoperative evaluation. Additional non-invasive flow measurements are useful in monitoring portal hypertension. The abdominal veins can be well imaged using unenhanced MR techniques. Imaging may be facilitated with intravascular contrast media. Contrast-enhanced 3D MRA can replace intra-arterial DSA for diagnosis, therapy planning and follow-up in patients with abdominal vascular disease. Catheter-based arteriography will still be used for interventional procedures such as percutaneous transluminal angioplasty, stent placement and embolisation.     

3D-CE MRA、2D-TOF MRA对颅内静脉窦血栓的诊断价值比较

目的比较3D—CEMRA和2D—TOFMRA对颅内静脉窦血栓的诊断价值。资料与方法8例经临床及影像学随访证实的颅内静脉窦血栓患者及8例健康志愿者分别行3D—CEMRA和2D—TOFMRA检查。由两名放射学医师共同回顾性阅片取得一致意见,病变组分别比较两种MRA技术单独应用MIP和MIP联合MPR、CPR及原始图像对血栓部位、血栓范围、窦腔闭塞及侧支静脉的检出率。对照组仅在MIP和原始图像上观察颅内静脉走行形态、信号强度。结果血栓共累及了20处颅内静脉窦,其中上矢状窦7处,窦汇区、左侧乙状窦及左侧横窦各2处,右侧横窦、右侧乙状窦各3处,右侧颈静脉球1处。在显示颅内静脉窦血栓范围、窦腔闭塞程度及侧支静脉方面,3D—CEMRA优于2D．TOFMRA（P值均〈0．01）。3D—CEMRA采用MIP联合MPR、CPR及原始图像优于单独采用MIP（P值〈0．01）。2D—TOFMRA采用MIP联合MPR、CPR及原始图像和单独采用MIP比较,二者并无明显差异（P值〉0．01）。结论对颅内静脉窦血栓的评价,3D—CEMRA优于2D—TOFMRA,多种后处理技术的联合应用能更好显示血栓的范围、窦腔闭塞的程度和侧支静脉循环。     

Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A).

The purpose of this study was to study temporal changes in signal intensity of liver, spleen, abdominal vessels, and focal liver lesions following iv bolus injection of a superparamagnetic iron oxide (SPIO) using a breath-held three-dimensional magnetic resonance angiography (3D-MRA) sequence. Dynamic SH U 555 A-enhanced 3D-MRA studies were performed in 20 patients with focal liver lesions. Sequential coronal 3D-MRA-FISP scans were acquired (TR 5.0 msec, TE 2.0 msec, flip angle 25 degrees, 140 x 256 matrix, and 80 mm slab) within 15 seconds. Scanning was started immediately after bolus injection of 10 micromol Fe/kg bodyweight and was repeated at multiple time points (baseline and 30, 60, 90, 120, 180, 240, 300, 360, and 420 seconds). Signal intensity values of liver, focal liver lesions, spleen, the portal venous system, the abdominal aorta, and the inferior vena cava were obtained to calculate relative enhancement (ENH = [SI post - SI pre]/SI pre x 100). Visibility of vessels was assessed by consensus of two readers. Signal enhancement within abdominal vessels peaked during the first pass; however, significant signal enhancement was still present 420 seconds following injection. The liver and the spleen also demonstrated a biphasic enhancement pattern with prolonged parenchymal enhancement. Dynamic MRA with bolus injectable SH U 555 A is clinically feasible, and significant vessel enhancement can be achieved even at the dose of 10 micromol Fe/kg bodyweight. However, further refinements are required to improve contrast effects.     

Magnetic resonance angiography of supratentorial tumours: comparison with selective digital subtraction angiography

We compared magnetic resonance angiography (MRA) and intra-arterial digital subtraction angiography (IADSA) in the study of brain tumours and assessed the utility of gadolinium-enhanced MRA. We studied 17 patients with supratentorial brain tumors. The entire brain was imaged with multiple overlapping thin volume acquisitions. After IV injection of gadolinium-DTPA, a single thick-slab MRA acquisition was performed. Standard three-dimensional (3D-TOF) acquisitions (in six patients) and 3D-TOF with magnetization transfer prepulse and tilted optimisation nonsaturing radiofrequency excitation pulses (in 11 patients) were used. Displacement of the anterior cerebral artery, main stem and insular branches of the middle cerebral artery was seen well on unenhanced and contrast-enhanced MRA. Displacement of the lenticulostriate and anterior choroidal arteries was seen only once, after Gadolinium. Tumour encasement of the middle cerebral artery was demonstrated in one patient. Tumour vessels were seen in 2 of 8 cases before and 3 of 8 after gadolinium; Tumour hypervascularity was seen only after gadolinium, in 3 of 8 cases. Study of the veins was possible only on gadolinium-enhanced MRA. Displacement of the venous angle was seen in 4 of 7 patients in the frontal, and in all of 8 patients on the lateral projections. Early venous drainage was not seen. Patency of the dural venous sinuses was demonstrated in all patients, but in one neoplastic occlusion of a cortical vein was recognised.     

门静脉海绵样变性的MRI诊断

目的 探讨门静脉海绵样变性(CTPV)的MR平扫及动态增强、动态对比增强MRA(DCE-MRA)的表现，评价MRI诊断CTPV的价值及临床意义。资料与方法 分析28例CTPV患者的MR平扫、动态增强或DCB-MRA资料，所有病例均经手术病理或DSA证实。结果 CTPV的MRI表现：平扫时可见门静脉闭塞，闭塞门静脉周围可见由侧支静脉形成的团块状、网状异常软组织信号影。动态MR增强动脉期见肝实质灌注异常，门静脉期见异常侧支静脉强化，DCE-MRA显示上述改变更直观。结论 MR平扫及动态增强、DCE-MRA表现对CTPV具有重要的诊断价值。     

Noncontrast 3D steady state free precession magnetic resonance angiography of the thoracic central veins using nonselective radiofrequency excitation over a large field of view: initial experience

PURPOSE: To evaluate the feasibility of three-dimensional (3D) steady state free precession (SSFP) magnetic resonance angiography (MRA) using nonselective radiofrequency excitation for the assessment of thoracic central veins. MATERIALS AND METHODS: Thirty consecutive patients (17 males, 13 females, age range 22-76) with various cardiac and thoracic vascular diseases underwent free-breathing electrocardiogram-gated noncontrast SSFP MRA and conventional high-resolution 3D contrast-enhanced (CE) MRA of the thorax at 1.5 T. Two readers evaluated both datasets for findings: venous visibility and sharpness (from 0, not visualized to 3, excellent definition); artifacts; signal-to-noise ratio (SNR); and contrast-to-noise ratio (CNR) in 8 venous segments including superior vena cava (SVC), supra-diaphragmatic inferior vena cava, bilateral brachiocephalic, proximal subclavian, and lower internal jugular veins. Statistical analysis was performed using Wilcoxon test for overall image quality and vessel visibility, t test for SNR and CNR analysis, and kappa coefficient for inter-observer variability. RESULTS: 3D SSFP and CE-MRA were successfully performed in all patients. Scan time for SSFP MRA ranged from 5 to 10 minutes (mean +/- standard deviation, 7 +/- 2 minutes). Reader 1 (2) graded the overall image quality as excellent and good on SSFP MRA in 23 (25) and 7 (5) patients, and on CE-MRA in 22 (23) and 8 (9) patients, respectively. On SSFP MRA, readers 1 and 2 graded 234 (97.5%) and 233 (97.1%) venous segments with diagnostic definition (grades 2 and 3) (kappa = 0.69), respectively. On conventional CE-MRA, readers 1 and 2 graded 231 (96.3%) and 232 (96.7%) venous segments with diagnostic definition (grades 2 and 3) (kappa = 0.68), respectively. Segmental visibility and sharpness were higher for lower internal jugular veins on CE-MRA for each reader (P < 0.001). No significant difference existed for venous visibility and sharpness scores for other venous segments between the 2 techniques for both readers (P > 0.05). SNR and CNR values were lower for internal jugular veins on SSFP MRA (P < 0.001). No significant difference existed between SNR and CNR values for the other venous segments on SSFP and CE-MRA (P > 0.05 for all). The 2 readers demonstrated patent SVC Glenn shunt to main pulmonary artery (n = 3), patent extra cardiac Fontan shunt from inferior vena cava to pulmonary artery confluence (n = 2), and dilatation and thrombosis of SVC (n = 1) and right brachiocephalic vein (n = 1) on both datasets. CONCLUSION: Free breathing navigator-gated noncontrast 3D SSFP MRA with nonselective radiofrequency excitation provides high image quality and sufficient SNR and CNR for confident evaluation of thoracic central veins.     

动态对比增强MRA对门静脉海绵样变性的诊断

目的:探讨动态对比增强(DCE)MRI和对比增强MRA(DCE-MRA)诊断门静脉海绵样变性(CTPV)的价值及临床意义。方法:28例CTPV患者均行MR动态对比增强及动态对比增强MRA检查,分析所有病例MR动态增强、DCE-MRA表现及特征。结果:CTPV的MRI平扫时可见门静脉闭塞,闭塞门静脉周围可见由侧支静脉形成的团块状、网状异常软组织信号影。动态MR增强动脉期见肝实质灌注异常,门静脉期见异常侧支静脉强化,3DDCE-MRA显示上述异常改变,行DSA检查病例DCE-MRA与DSA表现一致。结论:CTPV具有特征性的MR动态增强、DCE-MRA表现,对CTPV的诊断及鉴别诊断具有重要价值,对临床制定治疗方案具有重要意义。     

Evaluation of breath-hold contrast-enhanced 3D magnetic resonance angiography technique for imaging visceral abdominal arteries and veins

RATIONALE AND OBJECTIVES: To evaluate the diagnostic value of breath-hold contrast-enhanced 3D magnetic resonance angiography (MRA) for assessment of the visceral abdominal arteries and veins in patients with suspected abdominal neoplasms. METHODS: Twenty-one patients underwent MR imaging on a 1.5 T unit using a body phased-array coil. MRA was performed with a 3D-FLASH sequence (TR 3.8 ms, TE 1.3 ms, flip angle 25 degrees, acquisition time 20 seconds), 8 to 12 seconds after an intravenous bolus injection of Gd-DTPA. The acquisition delay between the arterial and the portal venous phase was 12 seconds. The image quality and the degree of vascular involvement were evaluated using coronal source images and maximum intensity projection reconstructions. Diagnosis was confirmed by surgery/histology. RESULTS: Image quality was optimal in more than 85% of the patients (19/21 arterial phase and 17/21 portal venous phase). MRA correctly predicted vascular status in 20 of 21 patients (95%), with complete concordance between MRA results and surgical findings. In one patient with chronic pancreatitis, MRA demonstrated a false-positive finding that could not be confirmed surgically. CONCLUSIONS. Breath-hold contrast-enhanced 3D-MRA is a valuable technique for assessing visceral abdominal arteries and veins.     

MRA of the lower extremities in patients with pulmonary embolism using a blood pool contrast agent: initial experience

PURPOSE: To evaluate the feasibility of blood pool contrast-enhanced magnetic resonance angiography (MRA) to visualize the arterial and venous vessel tree and to detect deep venous thrombosis (DVT) of the lower extremities. MATERIALS AND METHODS: Nine consecutive patients with pulmonary embolism (mean age = 46 +/- 9) were randomized to various doses of NC100150 (between 0.75 and 6 mg of Fe/kg of body weight). A T1-weighted (T1W) 3D gradient recalled echo (GRE) sequence (TE = 2.0 msec, TR = 5.0 msec) was used. Two observers blinded to the dose of contrast agent assessed image quality, contrast attenuation, and appearance of thrombi. RESULTS: Qualitative assessment of overall MRA image quality and semiquantitative vessel scoring revealed good to excellent delineation of venous and arterial vessel segments independent of the dose of NC100150. However, quantitative region of interest analysis revealed a significantly higher signal-to-noise ratio (SNR) in the high-dose group than in the mid- and low-dose groups of NC100150 (P < 0.01). Between dose groups, the SNR was independent of vessel type (artery or vein) and vessel segment localization (proximal or distal). All seven venous thrombi (mean length = 7.2 +/- 0.95 cm) were characterized by a very low signal intensity (SI), which was only 16.6 +/- 7% of the SI in adjacent venous segments (P < 0.0001). CONCLUSION: High-quality MR angiograms of the lower extremities can be obtained using low concentrations of NC100150 in combination with a strong T1W 3D GRE sequence. The obvious delineation of venous thrombi suggests that this technique may be potentially used as a noninvasive "one-stop shopping" tool in the evaluation of thromboembolic disease.     

Effect of resovist on rats with different severities of liver cirrhosis

RATIONALE AND OBJECTIVES: Whether the degree of diffuse hepatic damage is correlated with the signal change on MR images after injection of superparamagnetic iron oxide (SPIO) particles was investigated. In addition, we investigated whether hepatic function deteriorates after injection of SPIO. METHODS: Seventy-six female Sprague-Dawley rats aged 3 to 4 weeks were given drinking water containing 0.03% thioacetamide (TAA) for 4 or 12 weeks to induce two grades of liver injury. Seventeen normal rats were served as a control. Normal and model rats were administered Resovist (10 micromol Fe/kg), and signal intensities in the liver on MR images obtained at 4.7 T were measured up to 60 minutes after injection (n = 5). The model rats were injected with 10 times the envisaged dose of Resovist (100 micromol Fe/kg) or saline as a control substance, and blood parameters were measured at 4, 24, and 48 hours after injection (n = 5 or 6). At 4 hours after injection, iron and Kupffer cells in the liver were stained (n = 3). RESULTS: Maximal signal reduction in the liver occurred 15 minutes after injection in all groups. The reduced signal persisted for 60 minutes after injection. However, the degree of maximal signal reduction in the model rats was significantly less than that in the normal rats (P < 0.05, 0.01). Signal reduction in the 12-week group was less than that in the 4-week group. In control rats, the number of iron-positive cells increased by 22 cells per area (0.065 mm(2)) following treatment with Resovist. In the 4-week and 12-week groups, numbers of iron-positive cells increased by 13 and 11 cells, respectively. There was no statistically significant difference in the number of Kupffer cells between control and model rats. No significant change was observed in blood parameters with Resovist. CONCLUSION: The MR signal induced by Resovist depended on the degree of phagocytic activity in the liver. The safety profiles of Resovist remained unchanged even at 10 times the imaging dose.     

Contrast-enhanced 3D-TOF MRA of peripheral vessels: Intravascular versus extracellular MR contrast media

MR contrast media have been used to improve MR angiography (MRA). Their effect has been particularly beneficial for extracranial MRA. This study evaluated the efficacy of a new formulation of ultrasmall super-paramagnetic iron oxide particles (USPIO) on three-dimensional (3D) time of flight (TOF) MRA in the pelvis and lower limb circulation. Each of six dogs received 3 mg/kg of USPIO and .2 mmol/kg of gadolinium-dieth-ylenetriamine pentaacetic acid (Gd-DTPA) bis-meth-ylamide (BMA) by intravenous infusion on separate examinations. Precontrast and postcontrast 3D-TOF MRA images of the lower extremities were acquired over the course of 45 minutes postinjection. Signal intensity (SI) was measured on axial views along the external iliac, femoral, and popliteal arteries. USPIO provided clear demarcation of the major primary, secondary, and tertiary vessels and the improved contrast-to-noise ratio (CNR) was maintained for 45 minutes. Gd-DTPA-BMA provided less signal enhancement than USPIO. The increase in CNR with this agent had significantly declined by 15 minutes after injection. The major vessels could no longer be visualized at 30 and 45 minutes after injection of Gd-DTPA-BMA. This study demonstrates the efficacy of USPIO as a contrast medium for 3D-TOF MRA. It was concluded that USPIO provided effective and persistent enhancement of the peripheral vessels.     

Magnetic resonance portography using contrast-enhanced fat-saturated three-dimensional steady-state free precession imaging

PURPOSE: To assess the feasibility of contrast-enhanced fat-saturated three-dimensional steady-state free precession (FIESTA) imaging for contrast-enhanced magnetic resonance (MR) portography. MATERIALS AND METHODS: Contrast-enhanced fat-saturated three-dimensional fast spoiled gradient-echo (SPGR) and FIESTA were performed as MR portography. In 10 cases, fat-saturated three-dimensional FIESTA was first performed and followed by fast SPGR, and the order of post-contrast imaging was reversed in the other 10 cases. Signal-to-noise ratios (SNRs) and contrast-to-noise ratios (CNRs) were estimated for portal and visceral veins on the source images. The visualization of portal vein was scored on three-dimensional MR portography. Portal venous system disorders were assessed using three-dimensional MR portography. RESULTS: The SNRs, CNRs, and visual assessment of portal and visceral veins were significantly higher in contrast-enhanced fat-saturated three-dimensional FIESTA than contrast-enhanced fat-saturated three-dimensional fast SPGR (P < 0.05). The contrast-enhanced fat-saturated three-dimensional FIESTA provided high venous signals even at 8 minutes after gadolinium injection. The abnormalities of portal venous system were well visualized with MR portography using contrast-enhanced fat-saturated three-dimensional FIESTA. CONCLUSION: Contrast-enhanced fat-saturated three-dimensional FIESTA was valuable for MR portography, with flexible time window and high vascular signals. This imaging may allow for other post-contrast imaging options before portography and release patients from consecutive breath-holds.     

Contrast-enhanced MR angiography of intracranial giant aneurysms

BACKGROUND AND PURPOSE: Intravoxel phase dispersion and flow saturation often prevent adequate depiction of intracranial giant aneurysms on 3D time-of-flight (3D-TOF) MR angiography (MRA). Additional diagnostic difficulties may arise from T1 contamination artifact of an associated blood clot. Our aim was to assess whether contrast-enhanced MRA could improve the evaluation of giant aneurysms and to compare two different types of contrast-enhanced MRA. METHODS: We studied 11 aneurysms in 10 patients (age range, 31-77 years) with giant aneurysms of the anterior (n = 9) and posterior (n = 2) cerebral circulation by comparing 3D-TOF, first-pass dynamic contrast-enhanced MRA, and steady-state contrast-enhanced 3D-TOF sequences. Additional comparison with digital subtraction angiography (DSA) was performed in eight aneurysms. RESULTS: In nine of 11 aneurysms, 3D-TOF did not adequately show the lumen and exiting vessels. Contrast-enhanced 3D-TOF and dynamic contrast-enhanced MRA showed the aneurysm sac and exiting vessels in all of these cases. Dynamic contrast-enhanced MRA showed a better intravascular contrast than did contrast-enhanced 3D-TOF, which led to better delineation of the aneurysms. T1 contamination artifact from intra- or extraluminal blood clot was evident on the 3D-TOF images in four cases. The artifact was less marked on the contrast-enhanced 3D-TOF image and was completely eliminated on the dynamic contrast-enhanced MRA image by subtraction of precontrast images. The diagnostic information provided by dynamic contrast-enhanced MRA was comparable to that provided by DSA. CONCLUSION: Precontrast 3D-TOF is inadequate for the assessment of giant cerebral aneurysms. Both contrast-enhanced 3D-TOF and dynamic contrast-enhanced MRA reliably show the aneurysm sac and connected vessels. Dynamic MRA provides a superior contrast between flow and background and eliminates T1 contamination artifact. It should therefore be considered as the MRA sequence of choice.